Yunfei (Frank) Zhu is the Chief Research Officer at Radionetics Oncology. Prior to this role, Zhu was the Co-founder and Vice President, Chemistry at Crinetics Pharmaceuticals. With a background in medicinal chemistry, Zhu has played key roles in the discovery and development of novel treatments for various diseases targeting G-protein coupled receptors. Starting as a Senior Research Chemist at BioResearch, Zhu has worked his way up the ladder, earning promotions and contributing significantly to the pharmaceutical industry.
October, 2021 - present